Results 51 to 60 of about 2,421 (106)

CD3xCD20 bispecific antibodies in transformed Waldenström macroglobulinemia/lymphoplasmacytic lymphoma

HemaSphere, Volume 10, Issue 3, March 2026.
Morgane Brocard, Damien Roos‐Weil, Lukshe Kanagaratnam, Thomas Hueso, Lucile Bussot, Benjamin Papoular, Cécile Tomowiak, Steeve Chevreux, Gilles Crochet, Tristan Vaugeois, Elise Toussaint, Simone Ferrero, Charalampia Kyriakou, Anne Quinquenel, Prashant Kapoor, Eric Durot   +15 more
wiley   +1 more source

Evaluation externe de la qualité de la numération des lymphocytes T-CD4 au laboratoire d'immunologie et hématologie du CHU de Cocody

The Pan African Medical Journal, 2018
INTRODUCTION: Le taux de lymphocytes T-CD4 (LT4) est un paramètre crucial de suivi et de décision thérapeutique au cours de l'infection au Virus de l'Immunodéficience Humaine (VIH). Sa détermination doit être fiable et précise. Pour fournir des résultats
Koffi N’guessan, Yekayo Benedicte Koné, Oppong Richard Yéboah, Amah Patricia Goran-Kouacou, SérYRomuald Dassé   +4 more
doaj   +1 more source

Exploring the needs and resources of children in a haematology-oncology unit

Health SA Gesondheid: Journal of Interdisciplinary Health Sciences, 2011
Too often a child’s body is restored to health in the hospital, but the child is sent home with emotional wounds. This study explored the needs of children in a haematology-oncology unit as well as the resources that could be mobilised in order to ...
Annemarie E. Oberholzer, Elzabe Nel, Chris P.H. Myburgh, Marie Poggenpoel   +3 more
doaj   +1 more source

P-084: INFECTIOUS PROFILE OF SICKLE CELL PATIENTS IN THE HEMATOLOGY DEPARTMENTS OF CONAKRY UNIVERSITY HOSPITAL

HemaSphere, 2022
DIAKITE M., KANTE A., TOFOITA BINTY A., CAMARA F., SAKO F.   +4 more
doaj   +1 more source

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15− cells in early chronic‐phase chronic myeloid leukemia

Molecular Oncology, 2018
Despite the high efficiency of tyrosine kinase inhibitors (TKI), some patients with chronic myeloid leukemia (CML) will display residual disease that can become resistant to treatment, indicating intraclonal heterogeneity in chronic‐phase CML (CP‐CML ...
Stéphanie Maupetit‐Mehouas, Franck Court, Céline Bourgne, Agnès Guerci‐Bresler, Pascale Cony‐Makhoul, Hyacinthe Johnson, Gabriel Etienne, Philippe Rousselot, Denis Guyotat, Alexandre Janel, Eric Hermet, Sandrine Saugues, Juliette Berger, Philippe Arnaud, Marc G. Berger   +14 more
doaj   +1 more source

Pattern of care of prostate cancer patients across the Martinique: results of a population-based study in the Caribbean

BMC Cancer, 2018
Background The French West-Indies rank first for both prostate cancer incidence and mortality rates. Analyzing diagnostic and therapeutic procedures among patients with prostate cancer, using data from a population-based cancer registry, is essential for
Clarisse Joachim, Jacqueline Veronique-Baudin, Stephen Ulric-Gervaise, Jonathan Macni, Thierry Almont, Olivier Pierre-Louis, Lidvine Godaert, Moustapha Drame, Jean-Luc Novella, Karim Farid, Vincent Vinh-Hung, Patrick Escarmant   +11 more
doaj   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Posterior reversible encephalopathy syndrome (PRES) and myeloma

Leukemia Research Reports
Posterior reversible encephalopathy syndrome (PRES) has rarely been described in myeloma, but chemotherapy is a known risk factor. We report 3 patients with myeloma who developed PRES, and analyzed them with 13 published cases, mostly women.
Ricardos Ghanem, Sylvie Glaisner, Arthur Bobin, Anne-Marie Ronchetti, Sophie Cereja, Bertrand Joly, Célia Salanoubat, Guillemette Fouquet   +7 more
doaj   +1 more source

Soluble HLA-G Molecules Are Increased during Acute Leukemia, Especially in Subtypes Affecting Monocytic and Lymphoid Lineages'

Neoplasia: An International Journal for Oncology Research, 2006
Human leukocyte antigen G (HLA-G) molecules corresponding to nonclassic class I genes of the major histocompatibility complex exhibit immunomodulatory properties.
Frédéric Gros, Yasmine Sebti, Sophie de Guiber, Bernard Branger, Marc Bernard, Renée Fauchet, Laurence Amiot   +6 more
doaj   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source